Drug Shortage Report for HYDROMORPH CONTIN

Last updated on 2021-07-09 History
Report ID 140262
Drug Identification Number 02359502
Brand name HYDROMORPH CONTIN
Common or Proper name HYDROmorphone hydrochloride Controlled Release Capsules
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 4.5MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-06-03
Actual start date 2021-06-03
Estimated end date 2021-07-16
Actual end date 2021-07-08
Shortage status Resolved
Updated date 2021-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-07-09 English Compare
v12 2021-07-08 French Compare
v11 2021-07-08 English Compare
v10 2021-07-08 English Compare
v9 2021-06-30 French Compare
v8 2021-06-30 English Compare
v7 2021-06-23 French Compare
v6 2021-06-23 English Compare
v5 2021-06-15 French Compare
v4 2021-06-15 English Compare
v3 2021-06-04 English Compare
v2 2021-06-03 French Compare
v1 2021-06-03 English Compare

Showing 1 to 13 of 13